An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in public clinics. The country’s advisory group on ...

Two recent studies published this week assess the low uptake of respiratory syncytial virus (RSV) vaccine among US veterans ...

The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

Each year in the UK, 30,000 children under the age of five are hospitalised with RSV and it causes around 30 infant deaths.

New UK study shows RSV vaccine for pregnant women significantly reduces infant hospital admissions for severe respiratory ...

The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, making it easier than ever for eligible groups to get protected.

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...